Document Detail


Association between physical activity and blood pressure is modified by variants in the G-protein coupled receptor 10.
MedLine Citation:
PMID:  14691196     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hypertension is strongly related to cardiovascular disease and all-cause mortality. Exercise reduces blood pressure but the response varies between individuals. The mechanisms by which physical activity energy expenditure (PAEE) modifies blood pressure are not fully defined but include modulation of sympathetic tone. Novel polymorphisms in the G-protein coupled receptor (GPR10) have been linked with high blood pressure. GPR10 may mediate the relationship between PAEE and blood pressure via central nervous mechanisms. We examined whether two GPR10 polymorphisms (G-62A and C914T) modify the association between PAEE and blood pressure in the MRC Ely study (N=687). When stratified by the C914T genotype, there were between-group differences for body mass index (BMI) (P=0.05), diastolic blood pressure (DBP) (P=0.006), and systolic blood pressure (SBP) (P=0.005). No differences were found between G-62A genotypes. The previously reported inverse relationship between PAEE and blood pressure was not observed in minor allele carriers for either polymorphism (A62 carriers: DBP beta-1.11, P=0.52; SBP beta-1.66, P=0.52. T914 carriers: SBP beta=3.27; P=0.60) but was in common allele homozygotes (G62G: DBP beta-6.18 P=0.00001; SBP beta-8.54 P=0.0001. C914C: SBP beta-7.07; P=0.00001). This corresponded to a significant interaction between PAEE and GPR10 polymorphisms on DBP (G-62A: P=0.006) and SBP (G-62A: P=0.008. C914T: P=0.068). Significant interactions were observed between haplotype (derived from G-62A and C914T), PAEE, and blood pressure (DBP: P=0.08; SBP: P=0.023). The effect of physical activity on blood pressure is highly variable at population level. Knowledge of GPR10 genotype may define those who are least likely to benefit from physical activity. These findings may have relevance in the targeted treatment of hypertensive disease.
Authors:
Paul W Franks; Sumit Bhattacharyya; Jian'an Luan; Carl Montague; John Brennand; Benjamin Challis; Søren Brage; Ulf Ekelund; Rita P S Middelberg; Stephen O'Rahilly; Nicholas J Wareham
Related Documents :
19669396 - The hemodynamic pattern of the syndrome of delayed orthostatic hypotension.
9391506 - Nationwide prevalence study of hypertension and related non-communicable diseases in th...
19067736 - Elevated vegf-plasma levels in young patients with mild essential hypertension.
20535586 - Nicardipine infusion for blood pressure control in patients with subarachnoid hemorrhage.
15531006 - Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficac...
9891636 - Ventilation in the patient with unilateral lung disease.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2003-12-22
Journal Detail:
Title:  Hypertension     Volume:  43     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2004 Feb 
Date Detail:
Created Date:  2004-01-30     Completed Date:  2004-04-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  United States    
Other Details:
Languages:  eng     Pagination:  224-8     Citation Subset:  IM    
Affiliation:
University of Cambridge, Department of Public Health and Primary Care, Cambridge, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure / genetics*
Energy Metabolism
Exercise*
Female
Genotype
Haplotypes
Humans
Male
Middle Aged
Polymorphism, Single Nucleotide*
Receptors, G-Protein-Coupled / genetics*
Chemical
Reg. No./Substance:
0/PRLHR protein, human; 0/Receptors, G-Protein-Coupled

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction.
Next Document:  Mediators of bradykinin-induced vasorelaxation in human coronary microarteries.